|
Re: New version of May slide deck and ERA-EDTA Conference & Symposium
|
3
|
Resverlogix Corp.
|
Jun 27, 2018 04:23PM
|
|
Apabetalone and FXR
|
9
|
Resverlogix Corp.
|
Jun 27, 2018 04:55PM
|
|
5 year anniversary, ESC 2018 update and Amarin/REDUCE-IT
|
4
|
Resverlogix Corp.
|
Jun 28, 2018 03:22PM
|
|
Enzalutamide effective in non-metastatic prostate cancer
|
7
|
Zenith Epigenetics
|
Jun 28, 2018 04:26PM
|
|
Re: Enzalutamide effective in non-metastatic prostate cancer
|
5
|
Zenith Epigenetics
|
Jun 29, 2018 10:51AM
|
|
Updates from Mark Day
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jun 29, 2018 04:40PM
|
|
AGM Sept. 12, 2018
|
4
|
Resverlogix Corp.
|
Jun 29, 2018 04:45PM
|
|
AGM Sept. 12, 2018
|
3
|
Zenith Epigenetics
|
Jun 29, 2018 04:45PM
|
|
Re: AGM Sept. 12, 2018
|
5
|
Zenith Epigenetics
|
Jun 30, 2018 10:59AM
|
|
Re: AGM Sept. 12, 2018
|
5
|
Resverlogix Corp.
|
Jun 30, 2018 11:02AM
|
|
Re: orphan diseases
|
3
|
Resverlogix Corp.
|
Jul 01, 2018 09:19AM
|
|
American Thoracic Society 2018 International Conference
|
9
|
Resverlogix Corp.
|
Jul 01, 2018 08:44PM
|
|
Melanotransferrin receptor vs. Transferrin Recepor
|
4
|
BIOASIS TECHNOLOGIES INC
|
Jul 02, 2018 03:25PM
|
|
Resverlogix needs to host another R&D Day for Investors and Analysts
|
4
|
Resverlogix Corp.
|
Jul 03, 2018 10:24AM
|
|
Re: Resverlogix needs to host another R&D Day for Investors and Analysts
|
|
Resverlogix Corp.
|
Jul 03, 2018 04:52PM
|
|
Re: ...Oh well...
|
1
|
Resverlogix Corp.
|
Jul 03, 2018 04:55PM
|
|
Re: Biogen soars -- finds link between amyloid beta and Alzheimer's
|
4
|
Resverlogix Corp.
|
Jul 06, 2018 02:58PM
|
|
Re: Biogen soars -- finds link between amyloid beta and Alzheimer's
|
4
|
Resverlogix Corp.
|
Jul 06, 2018 04:31PM
|
|
SAB meeting and Corporate Presentation
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jul 09, 2018 12:12PM
|
|
Re: $2.72 just 4 more cents for a new 52 week high....
|
5
|
Resverlogix Corp.
|
Jul 11, 2018 10:54AM
|
